Kiran Mazumdar Shaw settles 'insider trading case' with Sebi in Infy matter

Accordingly, she filed a settlement application without admitting or denying the default and remitted Rs 3,01,758 in September 2019.

Kiran Mazumdar-Shaw, CMD, Biocon
Kiran Mazumdar-Shaw, CMD, Biocon
Press Trust of India New Delhi
2 min read Last Updated : Nov 22 2019 | 2:51 AM IST

Kiran Mazumdar Shaw, lead independent director of Infosys, has settled with Sebi a case of alleged delay in making disclosure regarding change in her shareholding in the IT company by paying over Rs 3 lakh as settlement charge.

Mazumdar Shaw, who is also a chairman of Biocon, was alleged to have violated provisions of the Prohibition of Insider Trading (PIT) regulations.

The Securities and Exchange Board of India (SEBI) had conducted an examination in the matter of Infosys and observed that Mazumdar Shaw had delayed making the requisite disclosures with respect to change in her shareholding in the company.

However, before proceeding further and initiating proceedings against her, the regulator sent notice of settlement to her, intimating that the proceedings may be settled and disposed of upon filing of an application settlement mechanism of Sebi along with remittance of settlement amount of over Rs 3.01 lakh.

Accordingly, she filed a settlement application without admitting or denying the default and remitted Rs 3,01,758 in September 2019.

"This order disposes of the proceedings that may be initiated for the defaults," Sebi said in an order passed on Wednesday.

Besides, it added that enforcement actions including commencing proceedings against the applicant may be taken if any representation made by the applicant is subsequently discovered to be untrue.

In February, Infosys had said that Mazumdar Shaw had inadvertently through her portfolio management services sold 1,600 shares of the company without obtaining pre-clearance of trade.

Following a review by the audit committee of the company's board of directors that determined that there was a violation of the Infosys' insider trading policy and the PIT norms, a penalty of Rs 9.5 lakh was imposed on Mazumdar Shaw.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Infosys Insider TradingBioconKiran Mazumdar ShawSebi

First Published: Nov 21 2019 | 5:00 PM IST

Next Story